TO AMEND SECTION 503 (b) OF THE FEDERAL FOOD, DRUG, AND COSMETIC ACT OF 1938, AS AMENDED
George P. Larrick, Deputy Commissioner, Federal Food and
Drug Administration, Federal Security Agency.
Roy S. Warnack, retail druggist, Los Angeles, Calif
Herman S. Waller, legal counsel, National Association of Retail
Druggists, Chicago, Ill.
Dunning, J. H. F., president, Hynson, Westcott & Dunning, Inc..
Ewing, Oscar R., Administrator, Federal Security Agency..
Fischelis, Robert P., secretary, American Pharmaceutical Association
Fonda, Howard B., president, American Pharmaceutical Manufac-
turers' Association___
Alphabetical list of witnesses-Continued
Harrop, eslie D., general counsel, American Drug Manufacturers Association__.
Hoge, James F., general counsel, The Proprietary Association__.
Larrick, George P., Deputy Commissioner, Food and Drug Adminis-
tration, Federal Security Agency-
Leake, James P., M. D., Washington, D. C.
Martin, Walter B., M.D., on behalf of American Medical Association_ Sibley, George H., vice president, E. R. Squibb & Sons___ Volwiler, Dr. Ernest H., president and general manager, Abbott
Warnack, Roy S., retail druggist of Los Angeles, Calif
Wheeler, W. M., Jr., secretary and general counsel, Eli Lilly & Co...
Department of the Treasury.
Statements, data and communications:
Fred Bartenstein, general attorney, Merck & Co., Inc.: Statement before Senate Labor and Public Welfare Committee on S. 1186 (Humphrey bill) in behalf of Merck & Co., Inc.
Stipulation entered into on Apr. 28, 1943, between the Federal
Trade Commission and Western Medical Corp., and amend-
ment thereto dated Apr. 9, 1948--
Letters and telegrams sent by Western Medical Corp. to patients
concerning the Durham-Humphrey bill
The reply of the Western Medical Corp. to the unsubstantiated
charges of the FDA.
Nicholas S. Gesoalde, secretary, New York State Pharmaceutical Asso-
ciation, New York, N. Y.: Statement of New York State Pharma-
ceutical Association presented to the chairman of the Subcommittee
on Health of the Committee on Labor and Public Welfare of the
Senate
James F. Hoge, general counsel, The Proprietary Association, New York, N. Y.: Supplemental statement on behalf of The Proprietary Association to the Subcommittee on Health of the Senate Labor and Public Welfare Committee on S. 1186 and H. R. 3298. Robert E. Kelly, retail druggist, Chicago, Ill.: Statement to the Senate Committee on Labor and Public Welfare on Senate bill S. 1186.
George P. Larrick, Deputy Commissioner of Food and Drugs, Food and
Drug Administration, Federal Security Agency:
Walter B. Martin, M. D., Norfolk, Va.: Letter dated Sept. 27, 1951, addressed to Hon. Herbert H. Lehman, dealing with the question whether barbiturates are habit-forming drugs
Herman S. Waller, legal counsel, National Association of Retail Drug-
gists:
Memorandum to the members of the Committee on Labor and
Public Welfare of the U. S. Senate re H. R. 3298 and S. 1186,
submitted by representatives of the National Association of
Retail Druggists, American Drug Manufacturers Association,
American Pharmaceutical Manufacturers' Association, and The
Proprietary Association_.
Aberdeen District Pharmaceutical Society, Aberdeen, N. C., telegram
dated Sept. 14, 1951, letter dated Sept. 13, 1951---
Brainard, Benson C., vice president, Lavoptik Co., Inc., St. Paul, Minn.,
letter dated Aug. 23, 1951.
Briggs, Cora Mae, executive secretary, Nebraska Pharmaceutical Associa-
tion, Lincoln, Nebr., letter dated Sept. 12, 1951
Bristol, Henry P., Bristol-Myers Co., New York, N. Y., letter dated Aug. 15, 1951
Burns, Jacob, New York, N. Y., letter dated Aug. 28, 1951.
Burroughs Wellcome & Co., Inc., Tuckahoe, N. Y., telegram dated Sept.
20, 1951, and letter dated Sept. 7, 1951.
Clark, A. H., the Mu-Col Co., Buffalo, N. Y., letter dated Aug. 13, 1951.
Clifford, Mabel B., secretary, Vermont Pharmaceutical Association,
Bethel, Vt., telegram dated Sept. 12, 1951__-
Doran, Alfred A., director of Professional Relations, Thomas Leeming &
Co., Inc., New York, N. Y., letter dated Aug. 31, 1951____
Durland, J. R., plant manager, Monsanto Chemical Co., telegram dated
Aug. 17, 1951.
Flanagan, James G., counsel, Drug, Chemical and Allied Trades Section, New York Board of Trade, Inc., New York, N. Y., letter dated Sept. 11,
Guarino, Michael, Richmond Hill, N. Y., letter dated Aug. 15, 1951-
Guciti, Mrs. Celia, New York, N. Y., telegram dated Sept. 13, 1951-
Haines, T. F. Davies, president, Ciba Pharmaceutical Products, Inc.,
Summit, N. J., telegram dated Sept. 17, 1951.
Hayden, Charles G., M. D., chairman, committee on national legislation,
the Massachusetts Medical Society, Boston, Mass., letter dated Aug. 10,
1951.
Hayden, Arthur H., trustee of the New York Pharmaceutical Co., Bedford,
Mass., letter dated Aug. 13, 1951.
« PreviousContinue » |